Home » Topics » BioWorld Science

BioWorld Science
RSS

TMR as adjunct to bypass surgery

Oct. 4, 1996

Prodesfarma presents cardiovascular candidate

Oct. 4, 1996

HLE inhibitors described by Zeneca

Oct. 4, 1996

Medeva terminates agreement with Chiesi related to dry powder inhaler

Oct. 4, 1996

Spotlight on LTD4 antagonists

Oct. 4, 1996

Axiom-Zaiya CD40 research collaboration

Oct. 4, 1996

Patent coverage for serine protease inhibitors licensed to Sparta

Oct. 4, 1996

Promising phase II results with APC-366

Oct. 4, 1996

Natural cAMP phosphodiesterase inhibitor reported by Nippon Kayaku

Oct. 4, 1996

Glaxo Wellcome decides not to develop oral asthma treatment

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...